poisar

Stocks · News reference

Vaxcyte, Inc. Stock 12-Month Price Target Adjusted by Analysts

Fiscal.ai

Analysts have slightly lowered the average 12-month price target for Vaxcyte, Inc. to $116.50, while maintaining a consensus “Buy” rating.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Vaxcyte, Inc. (PCVX)

    Filed: 2026-10-09 AccNo: 0001193125-26-419174 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits